Technology

  Global Saccharomyces Boulardii Market The  global Saccharomyces Boulardii market  was valued at US$ 275 million in 2024 and is anticipated to reach US$ 399 million by 2031, witnessing a CAGR of 5.6% during the forecast period 2025-2031. Saccharomyces boulardii is a probiotic yeast used for digestive health, notably for managing various types of diarrhea and for gut/immune support. Unlike most probiotics (which are bacteria), S. boulardii is a yeast—often positioned as complementary to bacterial strains because it survives alongside antibiotic therapy and tolerates GI conditions well. Demand is driven by rising GI disorders, antibiotic-associated dysbiosis, and a consumer shift toward preventative self-care supplements. Primary routes to market include pharmacies, hospitals, retail health aisles and direct-to-consumer e-commerce. Clinically backed positioning and the ability to formulate heat- and shelf-stable products (capsules, sachets) are central competitive levers. ...